Page 2 - Retrospective Study News Today

NEW YORK--(BUSINESS WIRE)--Sep 19, 2023--

CORAL GABLES, Fla., Aug. 14, 2023 -- Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel... -Today at 08:06 am- MarketScreener

THE Philippine Council for Agriculture and Fisheries (PCAF) reported that backyard farming is the number one risk factor associated with the spread of the African swine fever (ASF) in the Philippines.

NEW YORK--(BUSINESS WIRE)--Jun 23, 2023--

LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12 Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved

LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12

Real-world data and expert perspectives on state-of-the-art clinical practice for the management of infection in patients with CLL will be showcased during the Octapharma Update-in-Hematology session

Today's Water Cooler

New research found that certain systemic markers in psoriatic arthritis and psoriasis patients correlated with PASI scores, indicating the clinical relevance of platelets and neutrophils in inflammation.

New research shows predictions of dire consequences to consumers when companies merge often fall flat.